Inside Nigeria

NAFDAC Approves Oxford/AstraZeneca COVID-19 Vaccine

The Oxford/AstraZeneca COVID-19 vaccine has been approved for use by the National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria.

The vaccine was recently approved by the W.H.O for emergency use, in a press briefing, NAFDAC says it got the dossier of the vaccine a week ago, and the NAFDAC safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.

The Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a viral vector vaccine. Scientists used an adenovirus, originally derived from chimpanzees, and modified it with the aim of training the immune system to mount a strong response against SARS-CoV-2 (the virus that causes COVID-19).

Tags

Related Articles

Leave a Reply

WP2Social Auto Publish Powered By : XYZScripts.com
Close